Compare AMRX & MTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | MTG |
|---|---|---|
| Founded | 2002 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.6B |
| IPO Year | 2018 | 2008 |
| Metric | AMRX | MTG |
|---|---|---|
| Price | $21.24 | $28.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | $23.00 | ★ $30.83 |
| AVG Volume (30 Days) | ★ 2.8M | 2.4M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 2.37% |
| EPS Growth | ★ 157.89 | 8.65 |
| EPS | 0.37 | ★ 1.62 |
| Revenue | N/A | ★ $1,213,636,000.00 |
| Revenue This Year | $4.56 | N/A |
| Revenue Next Year | $9.33 | $1.04 |
| P/E Ratio | $56.70 | ★ $17.70 |
| Revenue Growth | N/A | ★ 0.49 |
| 52 Week Low | $9.99 | $24.69 |
| 52 Week High | $21.18 | $31.89 |
| Indicator | AMRX | MTG |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 54.68 |
| Support Level | $16.59 | $25.59 |
| Resistance Level | N/A | $31.62 |
| Average True Range (ATR) | 0.64 | 0.64 |
| MACD | 0.06 | 0.25 |
| Stochastic Oscillator | 93.21 | 78.74 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection account for close to the majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia, and New York.